VarmX

Restoring blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants

VarmX was founded in 2016, is headquartered in Leiden, Netherlands, lists 11–50 employees, and has $100.7M in recorded funding across 5 rounds.

Headquarters
Leiden
Employees
11–50
Founded
2016
Business Model
B2B
Website
varmx.com
Total Funding
$100.7M
Last Round
$16.5M GrantFeb 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

VarmX is a clinical-stage biotech company founded in 2016 as a spin-off from Leiden University Medical Center (LUMC), focused on developing a universal bypassing agent to restore blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa-DOACs). Its lead asset VMX-C001 targets severe bleeding events and surgical bleeding risk in patients on FXa-DOACs, a growing patient population with limited reversal options. The company has completed a €32M Series B financing and is preparing for a global Phase III pivotal trial.

Summary

VarmX is a Biotech company based in Leiden, Netherlands, founded in 2016. It lists 11–50 employees. It has raised $100.7M in total across 5 rounds, most recently a $16.5M Grant round in Feb 2025. Investors include European Innovation Council Fund, Ysios Capital and Sound Bioventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantFeb 2025
$16.5M

Sign up to see all 5 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VarmX on Indexed.vc
<a href="https://indexed.vc/companies/varmx"><img src="https://indexed.vc/api/badge/company/varmx" alt="VarmX on Indexed.vc" width="260" height="76" /></a>